...
首页> 外文期刊>International journal of gynecological cancer: official journal of the International Gynecological Cancer Society >Detection of micrometastases in cervical cancer with a system that evaluates both sentinel and nonsentinel lymph nodes.
【24h】

Detection of micrometastases in cervical cancer with a system that evaluates both sentinel and nonsentinel lymph nodes.

机译:用评估前哨淋巴结和非前哨淋巴结的系统检测宫颈癌中的微转移。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim is to reevaluate the accuracy of our sentinel lymph node (SLN) detection procedure and the use of SLN examination for detecting cervical cancer micrometastases. Patients affected by cervical cancer who underwent radical hysterectomy and total pelvic lymphadenectomy at Tohoku University Hospital from 2001 to 2003 were enrolled in this study. Patients in whom lymph node metastases were detected by routine histological examination or in whom no SLNs could be detected were excluded. Paraffin-embedded tissue blocks were cut into 3-microm thick slides at 200-microm intervals for both SLNs and non-SLNs. All lymph nodes were evaluated with step-serial sectioning and immunohistochemistry with an anticytokeratin antibody. One of the 10 patients had micrometastases, and 1 patient had isolated tumor cells (ITCs) in their SLNs. Thus, 2 (6%) of the 31 SLNs detected by our method had cancer cells. In contrast, none of the 309 non-SLNs obtained from 10 patients had micrometastases. The SLN micrometastases were detected in the right external iliac basin. The ITCs were detected in the left external iliac basin. The patient with micrometastases did not have vascular invasion but experienced recurrence. The case with ITCs had vascular invasion; however, she received adjuvant chemoradiotherapy and had no recurrence after 4 years. Our study suggests that only SLNs will contain micrometastases or ITCs, and non-SLNs will not. The SLNs detected by our method are probably real given the large total number of nodes evaluated. How micrometastases affect prognosis and the best way to detect them are areas of further study.
机译:目的是重新评估我们的前哨淋巴结(SLN)检测程序的准确性以及SLN检查在检测子宫颈癌微转移中的应用。这项研究纳入了2001年至2003年在东北大学医院进行了根治性子宫切除术和全盆腔淋巴结切除术的宫颈癌患者。通过常规组织学检查发现淋巴结转移或无法检测到SLN的患者被排除在外。将石蜡包埋的组织块以200微米的间隔切成3微米厚的玻片,用于SLN和非SLN。所有的淋巴结均通过连续切片和抗细胞角蛋白抗体的免疫组织化学进行评估。 10名患者中的1名患有微转移,1名患者的SLN中有孤立的肿瘤细胞(ITC)。因此,通过我们的方法检测到的31个SLN中有2个(6%)具有癌细胞。相比之下,从10例患者中获得的309种非SLN均无微转移。在右external外侧盆中检测到SLN微转移。在左external外侧盆中检测到ITC。微转移患者无血管侵犯,但复发。 ITC病例有血管侵犯;但是,她接受了辅助放化疗,并且在4年后没有复发。我们的研究表明,只有SLN会包含微转移或ITC,而非SLN则不会。考虑到评估的节点总数很大,通过我们的方法检测到的SLN可能是真实的。微转移如何影响预后以及检测它们的最佳方法是有待进一步研究的领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号